Answers are grounded in this paper and cite their sources.
Dietary modulation of responses to enteric infection involves functional interactions between the gut microbiota and mucosal immune responses. However, how ecological reshaping of microbial communities translates into protective immune adaptation remains unclear. Here, we examined the effects of chitosan oligosaccharide (COS) supplementation in a mouse model of Salmonella enterica serovar Typhimurium infection. COS-treated mice showed delayed mortality, reduced systemic bacterial burdens, improved epithelial barrier integrity, and attenuated inflammatory responses during Salmonella infection. These phenotypes were accompanied by changes in the colonic microbiota and metabolome, including increased relative abundance of Ligilactobacillus , higher abundance of indole-3-carboxylic acid (I3CA), and enhanced IgA-associated responses. Supplementation with Ligilactobacillus salivarius or I3CA recapitulated several phenotypes observed following COS treatment. Pharmacological inhibition of AhR attenuated I3CA-associated IgA responses. Antibiotic-mediated depletion of the microbiota diminished the protective phenotypes associated with I3CA administration, underscoring the contribution of an intact microbial ecosystem to I3CA-linked mucosal defense. Together, these findings support an association between COS supplementation and enhanced resistance to Salmonella infection, as well as coordinated changes in microbial indole metabolism, AhR signaling, and IgA responses.
No takes yet. Share an insight, caveat, or question.
Deng et al. (2026) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: